These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15579041)

  • 1. Activated MR contrast agents.
    Lowe MP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):519-28. PubMed ID: 15579041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
    Lanza GM; Winter P; Caruthers S; Schmeider A; Crowder K; Morawski A; Zhang H; Scott MJ; Wickline SA
    Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese enhanced magnetic resonance imaging.
    Lee JH; Koretsky AP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):529-37. PubMed ID: 15579042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer-based nanosized MRI contrast agents.
    Kobayashi H; Brechbiel MW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):539-49. PubMed ID: 15579043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.
    Aime S; Barge A; Cabella C; Crich SG; Gianolio E
    Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ.
    Ho C; Hitchens TK
    Curr Pharm Biotechnol; 2004 Dec; 5(6):551-66. PubMed ID: 15579044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring cell therapy using iron oxide MR contrast agents.
    Bulte JW; Kraitchman DL
    Curr Pharm Biotechnol; 2004 Dec; 5(6):567-84. PubMed ID: 15579045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of cell surface receptors using targeted contrast agents.
    Artemov D; Bhujwalla ZM; Bulte JW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):485-94. PubMed ID: 15579038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe.
    Tsai CP; Hung Y; Chou YH; Huang DM; Hsiao JK; Chang C; Chen YC; Mou CY
    Small; 2008 Feb; 4(2):186-91. PubMed ID: 18205156
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW; Kraitchman DL
    NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR techniques for in vivo molecular and cellular imaging.
    Delikatny EJ; Poptani H
    Radiol Clin North Am; 2005 Jan; 43(1):205-20. PubMed ID: 15693657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible target specific molecular imaging with ultrasound contrast agents].
    Mäurer M; Linker R; Reinhardt M; Hauff P
    Radiologe; 2005 Jun; 45(6):560-8. PubMed ID: 15912322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biomarker-responsive T
    Daryaei I; Randtke EA; Pagel MD
    Magn Reson Med; 2017 Apr; 77(4):1665-1670. PubMed ID: 27090199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
    Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
    Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
    Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G
    Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical application of functionalized magnetic nanoparticles.
    Ito A; Shinkai M; Honda H; Kobayashi T
    J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in molecular MRI.
    Sosnovik DE; Weissleder R
    Curr Opin Biotechnol; 2007 Feb; 18(1):4-10. PubMed ID: 17126545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heading toward Macromolecular and Nanosized Bioresponsive MRI Probes for Successful Functional Imaging.
    Angelovski G
    Acc Chem Res; 2017 Sep; 50(9):2215-2224. PubMed ID: 28841293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.